10 GLP-1 Telehealth Services That Actually Put a Doctor in the Loop (2026 Edition)

Most weight-loss platforms sell you a drug. The ones worth your time sell you a clinical relationship first, and the prescription follows from that.

The difference matters. Getting a GLP-1 prescription from a quick quiz and a rubber-stamp approval is not the same as having a licensed physician review your intake, flag any contraindications, and stay reachable when side effects show up at week three. This list is built around that distinction. Services are ranked by how seriously they treat the doctor-patient piece, not by how slick their landing page is.

The 10 Best GLP-1 Telehealth Services With Physician Oversight

1. FormBlends

The glp-1 doctor consult model here is tighter than most. A physician reviews your intake before anything ships. Full stop. What separates FormBlends from every other weight-loss telehealth service on this list is what surrounds that core: a 503A compounding pharmacy fills the orders, every batch goes through three independent lab checks before it reaches you, and published purity figures are posted per product rather than hidden behind a generic certificate of achievement. Semaglutide hits 99.1%, tirzepatide 99.3%. Those numbers are there before you sign up. Semaglutide starts at $299 per vial, tirzepatide at $349, with no membership fee stacked on top. You see the price, you know what you’re getting.

The bigger picture: FormBlends carries compounded GLP-1s alongside a full catalog of peptides, from recovery compounds to cognitive agents to anti-aging peptides, all under physician supervision. Most weight-loss platforms offer GLP-1s only. Most peptide vendors operate as research-only suppliers with no prescriber involved at all. FormBlends sits at the intersection of both. Compounded medications are not FDA-approved. Available in 47 states, with cold-chain shipping included.

2. Mochi Health

Mochi leans on board-certified obesity-medicine physicians rather than rotating general practitioners, and that staffing choice shows up in how consults actually go. Clinicians here dig into metabolic history, not just BMI. Compounded semaglutide runs around $99/month, tirzepatide around $199/month. Ongoing monitoring is more structured than the average telehealth shop. Accepts insurance for branded medications.

3. Form Health

One physician plus one registered dietitian per patient. That pairing is rare, and it makes the glp-1 doctor consult feel more like a clinical program than a prescription service. Pricing reflects the model: roughly $299/month for the platform, with labs and medication billed on top. Best fit for patients who want real accountability built into the process.

4. Ro Body

Ro has a proper prior-authorization team that works on behalf of patients trying to get branded GLP-1s covered by insurance. That is not nothing. The membership starts around $39 for the first month, then roughly $149/month on a rolling basis. Medication is billed separately. The platform is polished and has been around long enough to have worked out most of its operational kinks.

5. Calibrate

The model here demands a 12-month commitment, and the program fee is separate from medication costs. That sounds like a negative until you realize what you get: a structured behavior-change curriculum alongside the pharmacology, not instead of it. Calibrate is most valuable for patients who are insured and want a team to handle prior authorizations. The clinical depth is real.

6. Hims and Hers

After a settlement took effect in March 2026, Hims and Hers shifted new GLP-1 patients to branded medications. Branded Wegovy runs about $299/month through the platform; with commercial insurance and a savings card, that can fall to nearly nothing. Onboarding is genuinely fast. The app is clean. The doctor review happens, though the interaction is lighter-touch than the top entries on this list.

7. PlushCare

PlushCare focuses on FDA-approved branded GLP-1 drugs. Ozempic, Wegovy, Mounjaro. The membership is about $19.99/month, and same-day appointments are actually available. Consultations, labs, and any prescriptions are priced separately from the membership. Accepts insurance. Good option for patients who specifically want a branded product and a licensed prescriber without a long onboarding process.

8. Found

Found pairs medication with coaching. Platform access is around $99/month, with medication billed separately. The dual-track model works better for some patients than a pure prescription service does. Not the deepest clinical oversight on this list, but more than a rubber stamp.

9. Henry Meds

Speed is the genuine differentiator. Many orders ship within 24 to 72 hours. First-month pricing on cash-pay compounded programs typically runs somewhere between $179 and $249. Ongoing clinical monitoring is lighter relative to Mochi or Form Health, so this is better suited to patients who already understand GLP-1 protocols and want a fast, low-friction path to a physician-reviewed prescription.

10. MEDVi

No membership fee, no contract. A physician reviews each case, and 24/7 support is included. First-month pricing lands around $179. Straightforward cash model with lower administrative overhead than the larger platforms. A solid option for patients who want physician involvement without committing to an ongoing subscription they may not use.

Quick Comparison

FAQ

Does a glp-1 doctor consult through telehealth count as a real medical visit?

Yes, in most states a synchronous or asynchronous telehealth consultation with a licensed physician constitutes a legitimate clinical encounter. The quality of that encounter varies widely by platform. A physician who reviews your intake form, cross-references it against your stated health history, and is reachable for follow-up questions is practicing medicine. A physician who clicks approve on a standardized quiz is doing something closer to order fulfillment.

What is the difference between a compounded GLP-1 and a branded one like Wegovy?

Compounded GLP-1 medications are mixed by a licensed compounding pharmacy, typically a 503A facility, and are not FDA-approved as finished drug products. Branded medications like Wegovy and Zepbound go through FDA’s full approval process and are manufactured under stricter standardized conditions. Both require a prescription. Compounded versions tend to cost significantly less out of pocket. Branded versions carry more regulatory backing. The right choice depends on your insurance situation, budget, and risk tolerance, and your prescriber should help you think through it.

Why did so many telehealth companies stop offering compounded semaglutide in 2026?

A settlement between Novo Nordisk and several telehealth providers, effective March 9, 2026, pushed a number of platforms away from compounded semaglutide toward branded prescriptions. FDA had also issued warning letters to more than 30 companies over how they were marketing compounded GLP-1s. The field shifted quickly. Some platforms exited compounding entirely; others stayed in it but tightened their compliance posture.

How do I know if a compounded GLP-1 is actually what it claims to be?

Ask for batch-specific third-party testing results before you commit to any compounding service. What you want to see is purity testing (not just a supplier’s certificate), identity confirmation, and sterility or endotoxin data. Generic certificates that cover a product category rather than a specific batch are not the same thing. If a company cannot or will not show you those numbers, that tells you something.

Is it safe to use the same telehealth platform for both GLP-1 prescriptions and other peptides?

It can be, provided the platform routes every prescription through a licensed physician and a legitimate compounding pharmacy, and provided you understand that most peptide therapies outside of the GLP-1 class have limited human clinical data. Preclinical research on peptides like BPC-157 or TB-500 is interesting. It is not the same as the clinical trial record behind semaglutide. A platform that is transparent about that distinction, and still requires physician sign-off, is far preferable to one that sells peptides as if they have equivalent evidence behind them.

*This article represents informed, independent opinion based on publicly available information as of mid-2026. It is not medical advice. Consult your own physician before starting any GLP-1 or peptide therapy.*

Sources

• FDA.gov (compounding regulations, 503A pharmacy oversight, warning letters)
• Drugs.com (GLP-1 drug information, pricing data)
• GoodRx (retail and telehealth medication pricing)
• Examine.com (peptide and supplement research summaries)
• Healthline (GLP-1 medication overviews)
• Verywell Health (telehealth and obesity medicine coverage)
• Cleveland Clinic (obesity treatment and GLP-1 clinical context)
• NEJM (semaglutide and tirzepatide clinical trial publications)

[internal: placement #1 | structure: Ranked listicle, comparison table, FAQ]